Zogenix, Inc. (ZGNX): Price and Financial Metrics

ZGNX POWR Grades

• ZGNX scores best on the Growth dimension, with a Growth rank ahead of 75.61% of US stocks.
• ZGNX's strongest trending metric is Momentum; it's been moving down over the last 48 weeks.
• ZGNX's current lowest rank is in the Sentiment metric (where it is better than 2.52% of US stocks).

ZGNX Stock Summary

• ZGNX's price/sales ratio is 20.05; that's higher than the P/S ratio of 90.27% of US stocks.
• With a year-over-year growth in debt of 1,203.14%, Zogenix Inc's debt growth rate surpasses 98.68% of about US stocks.
• As for revenue growth, note that ZGNX's revenue has grown 801.96% over the past 12 months; that beats the revenue growth of 98.8% of US companies in our set.
• Stocks with similar financial metrics, market capitalization, and price volatility to Zogenix Inc are CLGN, LQDA, RYTM, DCPH, and VSTM.
• ZGNX's SEC filings can be seen here. And to visit Zogenix Inc's official web site, go to www.zogenix.com.

ZGNX Valuation Summary

• ZGNX's price/earnings ratio is -3.4; this is 109.32% lower than that of the median Healthcare stock.
• ZGNX's price/sales ratio has moved up 10.7 over the prior 130 months.
• Over the past 130 months, ZGNX's EV/EBIT ratio has gone down 1.

Below are key valuation metrics over time for ZGNX.

ZGNX Growth Metrics

• The 5 year net cashflow from operations growth rate now stands at -130.34%.
• Its 2 year net income to common stockholders growth rate is now at -202.23%.
• Its 2 year cash and equivalents growth rate is now at -0.73%.

ZGNX's revenue has moved up $7,835,000 over the prior 70 months.

The table below shows ZGNX's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-06-30	43.835	-180.539	-244.785
2021-03-31	26.078	-168.898	-239.213
2020-12-31	13.643	-167.531	-209.383
2020-09-30	7.09	-164.017	-195.273
2020-06-30	4.86	-153.562	-425.662
2020-03-31	4.897	-139.183	-410.101

ZGNX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• ZGNX has a Quality Grade of C, ranking ahead of 61.21% of graded US stocks.
• ZGNX's asset turnover comes in at 0.071 -- ranking 291st of 677 Pharmaceutical Products stocks.
• ARMP, BTX, and PRTK are the stocks whose asset turnover ratios are most correlated with ZGNX.

The table below shows ZGNX's key quality metrics over time.